Dihydropyrimidinones - A new class of anti-staphylococcal antibiotics

Bioorganic and Medicinal Chemistry Letters

Volumn 13, Issue 2, 2003, Pages 241-245

  Brands, Michael ^a   Endermann, Rainer ^a   Gahlmann, Reinhold ^a   Krüger, Jochen ^a   Raddatz, Siegfried ^a  

^a BAYER AG   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBIOTIC AGENT; ANTIINFECTIVE AGENT; PYRIDONE DERIVATIVE; TAN 1057 A,B; ANTINEOPLASTIC AGENT; DIPEPTIDE; PROTEIN SYNTHESIS INHIBITOR; PYRIMIDINONE DERIVATIVE; TAN 1057A;

ANIMAL CELL; ANTIBACTERIAL ACTIVITY; ARTICLE; DRUG SYNTHESIS; DRUG TOLERABILITY; MOUSE; NONHUMAN; STAPHYLOCOCCUS AUREUS; CELL CULTURE; CHEMISTRY; DRUG EFFECT; DRUG SCREENING; HUMAN; MACROPHAGE; METABOLISM; MICROBIOLOGICAL EXAMINATION; STAPHYLOCOCCUS; STRUCTURE ACTIVITY RELATION; SYNTHESIS;

ANTI-BACTERIAL AGENTS; ANTINEOPLASTIC AGENTS; DIPEPTIDES; DRUG SCREENING ASSAYS, ANTITUMOR; HUMANS; MACROPHAGES; MICROBIAL SENSITIVITY TESTS; PROTEIN SYNTHESIS INHIBITORS; PYRIMIDINONES; STAPHYLOCOCCUS; STRUCTURE-ACTIVITY RELATIONSHIP; TUMOR CELLS, CULTURED;

EID: 0037212105     PISSN: 0960894X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0960-894X(02)00880-6     Document Type: Article

References (21)

1. (a) Ehlert K. Curr. Pharm. Des. 5:1999;45.
2. (b) Marchese A., Schito G.C., Debbia E.A. J. Chemotherapy. 12:2000;459.
3. (c) Levy S.B. Clin. Microbiol. Infect. 6:2000;101.
4. (a) Katayama N., Fukusumi S., Funabashi Y., Iwahi T., Ono H. J. Antibiot. 46:1993;606.
5. (b) Funabashi Y., Tsubotani S., Koyama K., Katayama N., Harada S. Tetrahedron. 49:1993;13.
6. For total synthesis of TAN-1057 A, B, see: (a) Williams R.M., Yuan C. J. Am. Chem. Soc. 119:1997;11777. (b) Sokolov V.V., Kozhushkov S.I., Nikolskaya S., Belov V.N., Es-Sayed M., de Meijere A. Eur. J. Org. Chem. 1998;777. For the synthesis of analogues, see: (c) Williams R.M., Yuan C., Lee V.J., Chamberland S. J. Antibiotics. 51:1998;189. (d) Brands, M.; Es-Sayed. M.; Häbich, D.; Raddatz, S.; Krüger, J.; Endermann, R.; Gahlmann, R.; Kroll, H.-P.; Geschke, F.-U.; de Meijere, A.; Belov, V.; Sokolov, V.; Kozhushkov, S.; Kordes, M. WO 00/12484. (e) Brands M., Endermann R., Gahlmann R., Krüger J., Raddatz S., Stoltefuβ J., Belov V.N., Nizamov S., Sokolov V.V., de Meijere A. J. Med. Chem. 45:2002;4246.
7. For total synthesis of TAN-1057 A, B, see: (a) Williams R.M., Yuan C. J. Am. Chem. Soc. 119:1997;11777. (b) Sokolov V.V., Kozhushkov S.I., Nikolskaya S., Belov V.N., Es-Sayed M., de Meijere A. Eur. J. Org. Chem. 1998;777. For the synthesis of analogues, see: (c) Williams R.M., Yuan C., Lee V.J., Chamberland S. J. Antibiotics. 51:1998;189. (d) Brands, M.; Es-Sayed. M.; Häbich, D.; Raddatz, S.; Krüger, J.; Endermann, R.; Gahlmann, R.; Kroll, H.-P.; Geschke, F.-U.; de Meijere, A.; Belov, V.; Sokolov, V.; Kozhushkov, S.; Kordes, M. WO 00/12484. (e) Brands M., Endermann R., Gahlmann R., Krüger J., Raddatz S., Stoltefuβ J., Belov V.N., Nizamov S., Sokolov V.V., de Meijere A. J. Med. Chem. 45:2002;4246.
8. For total synthesis of TAN-1057 A, B, see: (a) Williams R.M., Yuan C. J. Am. Chem. Soc. 119:1997;11777. (b) Sokolov V.V., Kozhushkov S.I., Nikolskaya S., Belov V.N., Es-Sayed M., de Meijere A. Eur. J. Org. Chem. 1998;777. For the synthesis of analogues, see: (c) Williams R.M., Yuan C., Lee V.J., Chamberland S. J. Antibiotics. 51:1998;189. (d) Brands, M.; Es-Sayed. M.; Häbich, D.; Raddatz, S.; Krüger, J.; Endermann, R.; Gahlmann, R.; Kroll, H.-P.; Geschke, F.-U.; de Meijere, A.; Belov, V.; Sokolov, V.; Kozhushkov, S.; Kordes, M. WO 00/12484. (e) Brands M., Endermann R., Gahlmann R., Krüger J., Raddatz S., Stoltefuβ J., Belov V.N., Nizamov S., Sokolov V.V., de Meijere A. J. Med. Chem. 45:2002;4246.
9. For total synthesis of TAN-1057 A, B, see: (a) Williams R.M., Yuan C. J. Am. Chem. Soc. 119:1997;11777. (b) Sokolov V.V., Kozhushkov S.I., Nikolskaya S., Belov V.N., Es-Sayed M., de Meijere A. Eur. J. Org. Chem. 1998;777. For the synthesis of analogues, see: (c) Williams R.M., Yuan C., Lee V.J., Chamberland S. J. Antibiotics. 51:1998;189. (d) Brands, M.; Es-Sayed. M.; Häbich, D.; Raddatz, S.; Krüger, J.; Endermann, R.; Gahlmann, R.; Kroll, H.-P.; Geschke, F.-U.; de Meijere, A.; Belov, V.; Sokolov, V.; Kozhushkov, S.; Kordes, M. WO 00/12484. (e) Brands M., Endermann R., Gahlmann R., Krüger J., Raddatz S., Stoltefuβ J., Belov V.N., Nizamov S., Sokolov V.V., de Meijere A. J. Med. Chem. 45:2002;4246.
10. For total synthesis of TAN-1057 A, B, see: (a) Williams R.M., Yuan C. J. Am. Chem. Soc. 119:1997;11777. (b) Sokolov V.V., Kozhushkov S.I., Nikolskaya S., Belov V.N., Es-Sayed M., de Meijere A. Eur. J. Org. Chem. 1998;777. For the synthesis of analogues, see: (c) Williams R.M., Yuan C., Lee V.J., Chamberland S. J. Antibiotics. 51:1998;189. (d) Brands, M.; Es-Sayed. M.; Häbich, D.; Raddatz, S.; Krüger, J.; Endermann, R.; Gahlmann, R.; Kroll, H.-P.; Geschke, F.-U.; de Meijere, A.; Belov, V.; Sokolov, V.; Kozhushkov, S.; Kordes, M. WO 00/12484. (e) Brands M., Endermann R., Gahlmann R., Krüger J., Raddatz S., Stoltefuβ J., Belov V.N., Nizamov S., Sokolov V.V., de Meijere A. J. Med. Chem. 45:2002;4246.
11. BOC-Z-β-ornithine and BOC-Z-β-lysine were purchased from EMKA Chemical Enterprise, Ltd.
12. The racemic TAN-heterocylce was obtained according to ref 3b.
13. (a) Levallet C., Lerpiniere J., Ko S.Y. Tetrahedron. 53:1997;5291.
14. (b) Guo Z.-X., Cammidge A.N., Horwell D.C. Synth. Comm. 30:2000;2933.
15. (a) Li B., Franck R.W. Bioorg. Med. Chem. Lett. 9:1999;2629.
16. (b) Gomez-Monterrey I., Gonzalez-Muniz R., Herranz R., Garcia-Lopez M.T. Tetrahedron Lett. 34:1993;3593.
17. Ezquerra J., de Mendoza J., Pedregal C., Ramirez C. Tetrahedron Lett. 33:1992;5589.
18. Kearney P.C., Fernandez M., Flygare J.A. J. Org. Chem. 63:1998;196.
19. Tarling C.A., Holmes A.B., Markwell R.E., Pearson N.D. J. Chem. Soc., Perkin Trans. 1. 12:1999;1695.
20. (a) Müller M., Blobel G. Proc. Natl. Acad. Sci. U.S.A. 81:1984;7737.
21. (b) Escherichia coli S30 Extract System for Circular DNA, Technical Bulletin 092, Promega Corp.